GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Crescent Capital BDC Inc (NAS:CCAP) » Definitions » Change In Receivables

Crescent Capital BDC (Crescent Capital BDC) Change In Receivables : $-4.30 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Crescent Capital BDC Change In Receivables?

Crescent Capital BDC's change in receivables for the quarter that ended in Dec. 2023 was $11.75 Mil. It means Crescent Capital BDC's Accounts Receivable declined by $11.75 Mil from Sep. 2023 to Dec. 2023 .

Crescent Capital BDC's change in receivables for the fiscal year that ended in Dec. 2023 was $-4.30 Mil. It means Crescent Capital BDC's Accounts Receivable increased by $4.30 Mil from Dec. 2022 to Dec. 2023 .

Crescent Capital BDC's Accounts Receivable for the quarter that ended in Dec. 2023 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Crescent Capital BDC's Days Sales Outstanding for the three months ended in Dec. 2023 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Crescent Capital BDC's liquidation value for the three months ended in Dec. 2023 was $-877.01 Mil.


Crescent Capital BDC Change In Receivables Historical Data

The historical data trend for Crescent Capital BDC's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescent Capital BDC Change In Receivables Chart

Crescent Capital BDC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial -1.62 0.52 -17.77 11.68 -4.30

Crescent Capital BDC Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.57 -11.19 9.38 -14.23 11.75

Crescent Capital BDC Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Crescent Capital BDC  (NAS:CCAP) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Crescent Capital BDC's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/33.034*91
=0.00

2. In Ben Graham's calculation of liquidation value, Crescent Capital BDC's accounts receivable are only considered to be worth 75% of book value:

Crescent Capital BDC's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=7.78-884.785+0.75 * 0+0.5 * 0
=-877.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Crescent Capital BDC Change In Receivables Related Terms

Thank you for viewing the detailed overview of Crescent Capital BDC's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Crescent Capital BDC (Crescent Capital BDC) Business Description

Traded in Other Exchanges
Address
11100 Santa Monica Boulevard, Suite 2000, Los Angeles, CA, USA, 90025
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
Executives
Michael Scott Segal director C/O CRESCENT CAPITAL BDC, INC., 11100 SANTA MONICA BLVD., SUITE 2000, LOS ANGELES CA 90025
Steven F. Strandberg director C/O CRESCENT CAPITAL BDC, INC., 11100 SANTA MONICA BLVD., SUITE 2000, LOS ANGELES CA 90025
Strong George G. Jr. director C/O CRESCENT CAPITAL BDC, INC., 11100 SANTA MONICA BLVD., SUITE 2000, LOS ANGELES CA 90025
Susan Y Lee director 11100 SANTA MONICA BLVD, SUITE 2000, LOS ANGELES CA 90025
George Hawley officer: Secretary C/O CRESCENT CAPITAL GROUP LP, 11100 SANTA MONICA BLVD., SUITE 2000, LOS ANGELES CA 90025
Gerhard Lombard officer: Chief Financial Officer 600 FIFTH AVENUE, 19TH FLOOR, NEW YORK NY 10020
Erik G Barrios officer: Senior Vice President C/O CRESCENT CAPITAL GROUP, 299 PARK AVENUE, NEW YORK NY 10171
Kirill Bouek officer: Controller 10 HUDSON YARDS, 41ST FLOOR, NEW YORK NY 10001
Joseph Hanlon officer: Chief Compliance Officer C/O CRESCENT CAPITAL BDC, INC., 11100 SANTA MONICA BLVD., SUITE 2000, LOS ANGELES CA 90025
Jason Breaux officer: Chief Executive Officer C/O CRESCENT CAPITAL BDC, INC., 11100 SANTA MONICA BLVD., SUITE 2000, LOS ANGELES CA 90025
Raymond Barrios officer: Senior Vice President 11100 SANTA MONICA BLVD, SUITE 2000, LOS ANGELES CA 90025
Watsa V Prem Et Al 10 percent owner 95 WELLINGTON STREET WEST, SUITE 800, TORONTO A6 M5J 2N7
Elizabeth Ko director 11100 SANTA MONICA BLVD, SUITE 2000, LOS ANGELES CA 90025
Allied World Assurance Co Holdings, Gmbh 10 percent owner PARK TOWER, 15TH FLOOR, GUBELSTRASSE 24, ZUG V8 6300
Kathleen S Briscoe director GRIFFIN CAPITAL PLAZA, 1520 EAST GRAND AVENUE, EL SEGUNDO CA 90245

Crescent Capital BDC (Crescent Capital BDC) Headlines

From GuruFocus

Sun Life to Acquire Majority Stake in Crescent Capital Group LP

By Marketwired Marketwired 10-22-2020